Objective: Remifentanil hydrochloride is a new titratable opioid agonist wi
th rapid onset and offset of action. We present 2 cases of intracranial mas
s lesions in whom remifentanil was used to obtain serial neurological exami
nations. Methods: Patients received bolus doses of remifentanil 1 mug/kg fo
llowed by continuous infusions of 0.1-0.5 mug/kg/min, titrated to effect. A
fter the clinical examination, the remifentanil was restarted to the desire
d effect, Conclusion: The ultra-short duration of action of remifentanil ma
kes it ideally suited for selected pediatric neurosurgical patients in whom
frequent, serial neurological examinations are necessary, There were no si
de effects associated with the use of remifentanil, Copyright (R) 2001 S. K
arger AG, Basel.